Home / Companies / Astria Therapeutics, Inc. / 21 Jan 2026
Astria Therapeutics, Inc.: meeting of 21 Jan 2026
Votes reported on Form N-PX, item by item
207 Form N-PX filers reported votes at the Astria Therapeutics, Inc. meeting of 21 Jan 2026. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
4 vote records from 4 filers. 0 of the 2 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on pay tied to a merger or sale
307 vote records from 204 filers. 26 of the 194 filers that marked the item either way voted against management. 10 filers reported this item without a management mark.
EXTRAORDINARY TRANSACTIONSIssuer
EXTRAORDINARY TRANSACTIONS: management items
Management items in this category are shown together; filers word and number them differently.
116 vote records from 58 filers. 0 of the 58 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
140 vote records from 66 filers. 7 of the 66 filers that marked the item either way voted against management.
How the largest families voted
| Family | 2. Merger pay |
|---|---|
| Vanguard | For |
| BlackRock and iShares | For |
| Fidelity | For |
| Dimensional | For |
| State Street and SPDR | For |
| American Century | Against * |
| Invesco | For |
| Equitable | For |
| Charles Schwab | For |
| Nuveen and TIAA | Against * |
| ProShares and ProFunds | For |
| John Hancock and Manulife | For |
| Morgan Stanley, Eaton Vance and Calvert | For |
| J.P. Morgan | For |
| Goldman Sachs | For |
| PGIM and Prudential | For |
| Northern Trust and FlexShares | For |
| SEI | For |
| T. Rowe Price | For |
| Lincoln Financial | For |
| Voya | Against * |
| Russell Investments | For |
| Nationwide | For |
| Victory Capital | For |
| Brighthouse Funds | For |
| Guggenheim and Rydex | For |
| BNY Mellon | For |
| Principal | For |
| Pacific Life funds | For |
| Global X | For |
| AllianceBernstein | Against * |
| DWS | For |
| Virtus | For |
| Neuberger Berman | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Astria Therapeutics, Inc. meeting?
207 Form N-PX filers reported votes at the meeting of 21 Jan 2026. On say-on-pay, 0 of 2 voted against management (0.0%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Astria Therapeutics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Astria Therapeutics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Astria Therapeutics, Inc. with a meeting date within three days of 21 Jan 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.